5Small JG, Hirsch Sll, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high - and low - dose double - blind comparison with placebo [ J ]. Arch Gen Psychiat, 1997 ;54(3 ) :549 - 557
3Small JG,Hirsch SR,Arvantis A,et al.Quetiapine in patients with schizophrenia.A high and low-dose double-bind comparison with placebo[J].Arch Gen Psychiatry,1997,54:549.
4Widen P,Mcelrop SL,Griffin RA,et al.Quetiapine in the treatment resistant chronic schizophrenia:a randomized double-blind study[J].J Clin Psychiatry,1997,58:63.
5Arvanitis LA,Kandel ER.Quetiapine in the treatment of schizophrenia patient[J].Biol Psychiatry,1997,42:233.
6久住一郎,小山司.抗精神病藥の開發動向と問題点[J].臨床精神醫學,2004,263－267.
7Bowles TM, levin GM. Aripiprazole : A new atypical antipsychotic drug [ J ]. Ann pharmacother, 2003,37 : 687-694.
8Murasaki M. AD-5423 versus haloperidol in the treatment of schizophrenic patients: results of the Japan multicentle, double-blind trial [ J ]. Eur Neuropsychopharmacol, 2002,12 : 5268.
9Gunasekara NS, Spencer CM, Keating GM. Ziprasidone : a review of its use irt schizophrenia and schizoaffective disorder[ J ]. Drugs, 2002,62 :1217-1251.
8Gorwood P, Peuskens J. Setting new standards in schizophrenia out- comes: Symptomatic remission 3 years before versus after the an- dreasen criteria [J]. European Psychiatry, 2012, 27: 170-175.
9Shana GS, Jason S, Emily K, et al. Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizo- phrenia-spectrum disorder: a high-risk prospective investigation [J]. Schizophrenia Research, 2012, 139: 129-135.
10Fountoulakis KN, Vieta E, Schmidt F. Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-analysis [J]. Journal of Af- fective Disorders, 2011, 133: 361-370.
